Crossmark

How does nintedanib overcome cancer drug-resistant mutation of RET protein-tyrosine kinase: insights from molecular dynamics simulations

Published Online: 2021-11-02

Published Print: 2021-11

Authors

Cao, Shu

Jiang, Xu

Tan, Changbin

Fu, Ming

Xiong, Wenqing

Ji, Dong

Lv, Jun
License Information

Text and Data Mining valid from 2021-11-01

Version of Record valid from 2021-11-01
More Information

Article History

Received: 29 March 2021

Accepted: 22 October 2021

First Online: 2 November 2021

Declarations

:

: The authors declare no competing interests.

Document is current